Lundbeck receives US FDA fast track designation for Lu AH69593, an investigational orexin 2 receptor agonist for narcolepsy: Valby, Denmark Saturday, July 25, 2026, 16:00 Hrs [IST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results